Biodesix (BDSX) Enterprise Value (2019 - 2025)
Historic Enterprise Value for Biodesix (BDSX) over the last 7 years, with Q3 2025 value amounting to -$16.6 million.
- Biodesix's Enterprise Value rose 4713.11% to -$16.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$16.6 million, marking a year-over-year increase of 4713.11%. This contributed to the annual value of -$26.2 million for FY2024, which is 14.84% up from last year.
- Per Biodesix's latest filing, its Enterprise Value stood at -$16.6 million for Q3 2025, which was up 4713.11% from -$20.7 million recorded in Q2 2025.
- In the past 5 years, Biodesix's Enterprise Value ranged from a high of -$11.5 million in Q1 2024 and a low of -$56.3 million during Q2 2021
- Its 5-year average for Enterprise Value is -$28.7 million, with a median of -$25.3 million in 2023.
- Per our database at Business Quant, Biodesix's Enterprise Value crashed by 65477.32% in 2021 and then soared by 7031.03% in 2022.
- Biodesix's Enterprise Value (Quarter) stood at -$32.8 million in 2021, then crashed by 31.32% to -$43.1 million in 2022, then surged by 39.0% to -$26.3 million in 2023, then grew by 0.15% to -$26.2 million in 2024, then skyrocketed by 36.73% to -$16.6 million in 2025.
- Its last three reported values are -$16.6 million in Q3 2025, -$20.7 million for Q2 2025, and -$17.6 million during Q1 2025.